JD HEALTH INTL LTD (8ZN) — Capital Reinvestment Ratio

Latest as of June 2023: 0.11x

JD HEALTH INTL LTD (8ZN) has a Capital Reinvestment Ratio of 0.11x as of June 2023, meaning it reinvests 0% of its operating cash flow (€184.04 Million) in capital expenditures (€19.75 Million). See JD HEALTH INTL LTD balance sheet independence to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.11x
Capex / Operating Cash Flow

Operating Cash Flow

€184.04 Million
EUR

Capital Expenditures

€19.75 Million
EUR

Data as of

Jun 2023
Most recent filing

JD HEALTH INTL LTD Capital Reinvestment Ratio (2019–2025)

This chart tracks JD HEALTH INTL LTD's Capital Reinvestment Ratio across 7 annual periods. Check JD HEALTH INTL LTD (8ZN) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Annual Capital Reinvestment Ratio for JD HEALTH INTL LTD (2019–2025)

Year-by-year Capital Reinvestment Ratio for JD HEALTH INTL LTD from 2019 to 2025. For live market cap and broader valuation context, see 8ZN stock market capitalisation.

Year Reinvestment Ratio Operating CF (EUR) Capital Expenditures YoY Change
2025 0.01x €10.17 Billion €151.01 Million ▲ +38.7%
2024 0.01x €4.33 Billion €46.35 Million ▼ -28.9%
2023 0.02x €4.60 Billion €69.33 Million ▲ +121.4%
2022 0.01x €5.91 Billion €40.16 Million ▼ -95.4%
2021 0.15x €3.43 Billion €502.21 Million ▲ +3349.6%
2020 0.00x €3.70 Billion €15.70 Million ▼ -66.5%
2019 0.01x €409.47 Million €5.19 Million
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow